Polypharmacy and major adverse events in atrial fibrillation

Back

EHRA Premium Access

Polypharmacy and major adverse events in atrial fibrillation

Session: Optimal therapy of atrial fibrillation

Topic: Rhythm Control, Antiarrhythmic Drugs

Speaker: Doctor A. Papazoglou (Athens, GR)

Event: EHRA 2021

Congress Presentation

Add to my library

About the speaker

Doctor Andreas Papazoglou

Naval Hospital of Athens, Athens (Greece)

0 follower

7 more presentations in this session

Achieving acute mitral isthmus block with catheter ablation with vein of marshall ethanol infusion

Speaker: Doctor M. Andronache (Clermont-Ferrand, FR)

Bleeding risk and healthcare resource utilisation in elderly patients treated with edoxaban or vitamin K antagonists for atrial fibrillation in Italy

Speaker: Ms E. Smits (Utrecht, NL)

Antiarrhythmic drug responders among patients with recurrent atrial fibrillation after catheter ablation

Speaker: Doctor Y. Park (Daegu, KR)

Esophagus-to-posterior Atrial wall relationship: pre- and Intra-procedural three-dimensional multimodality imaging for esophageal position.

Speaker: Doctor C. Teres (Lausanne, CH)

The magnitude and the course of local impedance drop to guide successful AF ablation: insight from an Italian registry

Speaker: Doctor V. Schillaci (Mercogliano, IT)

Access the full session

Optimal therapy of atrial fibrillation

Speakers: Doctor A. Papazoglou, Doctor M. Andronache, Ms E. Smits, Doctor Y. Park, Doctor C. Teres...

Access

About the event

EHRA 2021

23 April - 25 April 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources